Activist 13D/13G Filings - MusclePharm Corp (MSLP)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2022-12-21
5:22 pm
Unchanged		13DMusclePharm Corp
MSLP		White Winston Select Asset Fund Series Fund MP-18 LLC3,021,529
8.800%		0
(Unchanged)		View
2022-04-01
4:38 pm
Sale		13DMusclePharm Corp
MSLP		White Winston Select Asset Fund Series Fund MP-18 LLC3,021,529
9.050%		-626,826decrease
(-17.18%)		View
2022-02-22
11:22 am
Unchanged		13DMusclePharm Corp
MSLP		White Winston Select Asset Fund Series Fund MP-18 LLC3,648,355
10.930%		0
(Unchanged)		View
2020-12-02
4:58 pm
Purchase		13DMusclePharm Corp
MSLP		Drexler Ryan Charles31,002,836
68.000%		11,349,057increase
(+57.74%)		View
2020-11-03
4:23 pm
Purchase		13DMusclePharm Corp
MSLP		WYNNEFIELD PARTNERS SMALL CAP VALUE LP I2,111,874
6.400%		100,000increase
(+4.97%)		View
2020-10-28
3:57 pm
Sale		13DMusclePharm Corp
MSLP		WYNNEFIELD PARTNERS SMALL CAP VALUE LP I2,011,874
6.100%		-31decrease
(-0.00%)		View
2020-07-13
2:07 pm
Purchase		13DMusclePharm Corp
MSLP		WYNNEFIELD PARTNERS SMALL CAP VALUE LP I2,011,905
6.200%		80,600increase
(+4.17%)		View